Back to Search

Study for Patients with Type 2 Diabetes

A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

Recruiting Observational Study
Type 2 Diabetes
More trials: Diabetes clinical trials· Diabetes trials in Arkansas
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
2,150 (estimated)
Sponsor
AstraZeneca · Industry
Who this trial is looking for

This trial is looking for adults with type 2 diabetes who want to participate in future studies. Participants will need to share their health information and follow study procedures.

Are You a Good Fit for This Trial?
Must not be taking GLP-1 receptor agonists
Rules you out Type 1 diabetesPregnancy

You may be able to join if

  • I am at least 18 years old.
  • I have been diagnosed with type 2 diabetes.
  • I have tried managing my diabetes with lifestyle changes and/or medications.
  • I have been on a stable dose of diabetes medication for at least 45 days.
  • I am interested in participating in diabetes studies.
  • I can commit to the study's requirements and procedures.
  • I have signed a consent form for this study.

You may not be able to join if

  • I currently take GLP-1 receptor agonists.
  • I have been diagnosed with type 1 diabetes.
  • I am pregnant or planning to become pregnant.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

The purpose of this study is to identify and characterize patients with known Type 2 Diabetes Mellitus (T2DM) for possible participation in ongoing or future T2DM clinical studies, and to characterize trends in key concomitant medication use in this patient population across different geographical regions.

Trial Locations

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Participants must be ≥ 18 years of age at the time of signing the ICF. * Patients with a diagnosis of T2DM, test- or documentation-confirmed as per World Health Organization or local diagnostic standards, inadequately managed with: 1. Lifestyle management alone, AND/OR 2. A …
Contacts

AstraZeneca Clinical Study Information Center

1-877-240-9479

information.center@astrazeneca.com

CONTACT

NCT ID: NCT07606066 Source: ClinicalTrials.gov